Physician profile
Michael Knotts
NPI 1912359415
$2,390.99
in general payments reported to CMS, 2019-2025
17 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $417 · 2022: $402 · 2023: $522 · 2024: $669 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $498.07 | 2021-2025 | |
| Novo Nordisk INC | $433.91 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $319.81 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $296.54 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $232.85 | 2023-2025 | |
| Exact Sciences Corporation | $108.93 | 2023-2025 | Cologuard Collection Kit |
| Renalytix Ai, INC. | $106.11 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Grt US Holding, INC. | $87.16 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.71 | 2022 | |
| Glaxosmithkline, LLC. | $50.70 | 2021-2023 | Boostrix, Shingrix, Fluarix Quadrivalent |
| Axsome Therapeutics, INC. | $41.49 | 2025 | Auvelity |
| Baxter Healthcare | $39.01 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Genentech USA, INC. | $32.02 | 2021 | |
| Amarin Pharma, INC. | $30.48 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $19.81 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $14.18 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Knotts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.